vs

Side-by-side financial comparison of BlackSky Technology Inc. (BKSY) and CareCloud, Inc. (CCLD). Click either name above to swap in a different company.

BlackSky Technology Inc. is the larger business by last-quarter revenue ($35.2M vs $34.4M, roughly 1.0× CareCloud, Inc.). On growth, CareCloud, Inc. posted the faster year-over-year revenue change (21.9% vs 15.9%). Over the past eight quarters, BlackSky Technology Inc.'s revenue compounded faster (20.5% CAGR vs 15.1%).

BlackSky Technology Inc. is a leading geospatial intelligence provider operating a constellation of high-revisit small Earth observation satellites. It delivers real-time satellite imagery, advanced data analytics, and dynamic monitoring solutions to government, defense, critical infrastructure, and commercial clients globally to support data-driven operational decision-making.

CareCloud, Inc. is a publicly traded American healthcare information technology company that provides services, to healthcare providers and hospitals. The Company maintains its headquarters in Somerset, New Jersey, and employs approximately 4,000 workers worldwide.

BKSY vs CCLD — Head-to-Head

Bigger by revenue
BKSY
BKSY
1.0× larger
BKSY
$35.2M
$34.4M
CCLD
Growing faster (revenue YoY)
CCLD
CCLD
+5.9% gap
CCLD
21.9%
15.9%
BKSY
Faster 2-yr revenue CAGR
BKSY
BKSY
Annualised
BKSY
20.5%
15.1%
CCLD

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
BKSY
BKSY
CCLD
CCLD
Revenue
$35.2M
$34.4M
Net Profit
$-868.0K
Gross Margin
Operating Margin
-11.8%
9.1%
Net Margin
-2.5%
Revenue YoY
15.9%
21.9%
Net Profit YoY
95.5%
EPS (diluted)
$0.04
$0.06

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BKSY
BKSY
CCLD
CCLD
Q4 25
$35.2M
$34.4M
Q3 25
$19.6M
$31.1M
Q2 25
$22.2M
$27.4M
Q1 25
$29.5M
$27.6M
Q4 24
$30.4M
$28.2M
Q3 24
$22.5M
$28.5M
Q2 24
$24.9M
$28.1M
Q1 24
$24.2M
$26.0M
Net Profit
BKSY
BKSY
CCLD
CCLD
Q4 25
$-868.0K
Q3 25
$-15.3M
$3.1M
Q2 25
$-41.2M
$2.9M
Q1 25
$-12.8M
$1.9M
Q4 24
$-19.4M
Q3 24
$-12.6M
$3.1M
Q2 24
$-9.4M
$1.7M
Q1 24
$-15.8M
$-241.0K
Operating Margin
BKSY
BKSY
CCLD
CCLD
Q4 25
-11.8%
9.1%
Q3 25
-85.8%
10.3%
Q2 25
-62.8%
10.9%
Q1 25
-40.5%
7.3%
Q4 24
-20.0%
12.2%
Q3 24
-58.7%
11.4%
Q2 24
-47.0%
8.1%
Q1 24
-54.7%
0.5%
Net Margin
BKSY
BKSY
CCLD
CCLD
Q4 25
-2.5%
Q3 25
-78.2%
9.8%
Q2 25
-185.8%
10.6%
Q1 25
-43.4%
7.0%
Q4 24
-63.9%
Q3 24
-55.8%
10.9%
Q2 24
-37.7%
6.0%
Q1 24
-65.2%
-0.9%
EPS (diluted)
BKSY
BKSY
CCLD
CCLD
Q4 25
$0.04
$0.06
Q3 25
$-0.44
$0.04
Q2 25
$-1.27
$0.04
Q1 25
$-0.42
$-0.04
Q4 24
$-0.61
$0.00
Q3 24
$-0.66
$-0.04
Q2 24
$-0.52
$-0.14
Q1 24
$-0.88
$-0.10

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BKSY
BKSY
CCLD
CCLD
Cash + ST InvestmentsLiquidity on hand
$124.5M
Total DebtLower is stronger
$201.1M
$1.2M
Stockholders' EquityBook value
$94.9M
$59.5M
Total Assets
$386.2M
$87.6M
Debt / EquityLower = less leverage
2.12×
0.02×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BKSY
BKSY
CCLD
CCLD
Q4 25
$124.5M
Q3 25
$146.5M
Q2 25
$93.8M
Q1 25
$75.8M
Q4 24
$52.5M
Q3 24
$63.2M
Q2 24
$41.2M
Q1 24
$35.4M
Total Debt
BKSY
BKSY
CCLD
CCLD
Q4 25
$201.1M
$1.2M
Q3 25
$195.1M
Q2 25
$122.5M
Q1 25
$115.3M
Q4 24
$107.7M
$336.0K
Q3 24
$98.8M
Q2 24
$108.6M
Q1 24
$85.0M
Stockholders' Equity
BKSY
BKSY
CCLD
CCLD
Q4 25
$94.9M
$59.5M
Q3 25
$91.1M
$57.8M
Q2 25
$86.6M
$56.1M
Q1 25
$88.8M
$54.2M
Q4 24
$94.0M
$49.8M
Q3 24
$110.3M
$46.5M
Q2 24
$76.5M
$43.2M
Q1 24
$81.7M
$41.4M
Total Assets
BKSY
BKSY
CCLD
CCLD
Q4 25
$386.2M
$87.6M
Q3 25
$380.9M
$90.6M
Q2 25
$310.8M
$75.2M
Q1 25
$284.9M
$73.6M
Q4 24
$254.1M
$71.6M
Q3 24
$245.5M
$70.7M
Q2 24
$224.3M
$74.0M
Q1 24
$210.1M
$76.9M
Debt / Equity
BKSY
BKSY
CCLD
CCLD
Q4 25
2.12×
0.02×
Q3 25
2.14×
Q2 25
1.41×
Q1 25
1.30×
Q4 24
1.15×
0.01×
Q3 24
0.90×
Q2 24
1.42×
Q1 24
1.04×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BKSY
BKSY
CCLD
CCLD
Operating Cash FlowLast quarter
$-9.3M
$8.7M
Free Cash FlowOCF − Capex
$6.6M
FCF MarginFCF / Revenue
19.0%
Capex IntensityCapex / Revenue
6.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$23.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BKSY
BKSY
CCLD
CCLD
Q4 25
$-9.3M
$8.7M
Q3 25
$-39.0M
$7.4M
Q2 25
$-7.3M
$7.4M
Q1 25
$27.2M
$5.1M
Q4 24
$-1.8M
$5.2M
Q3 24
$1.0M
$7.1M
Q2 24
$-1.8M
$4.3M
Q1 24
$-3.8M
$4.1M
Free Cash Flow
BKSY
BKSY
CCLD
CCLD
Q4 25
$6.6M
Q3 25
$6.5M
Q2 25
$6.2M
Q1 25
$4.5M
Q4 24
$4.3M
Q3 24
$6.7M
Q2 24
$4.2M
Q1 24
$3.8M
FCF Margin
BKSY
BKSY
CCLD
CCLD
Q4 25
19.0%
Q3 25
20.9%
Q2 25
22.8%
Q1 25
16.2%
Q4 24
15.2%
Q3 24
23.6%
Q2 24
14.8%
Q1 24
14.5%
Capex Intensity
BKSY
BKSY
CCLD
CCLD
Q4 25
6.2%
Q3 25
2.8%
Q2 25
4.2%
Q1 25
2.3%
Q4 24
3.3%
Q3 24
1.2%
Q2 24
0.5%
Q1 24
1.1%
Cash Conversion
BKSY
BKSY
CCLD
CCLD
Q4 25
Q3 25
2.41×
Q2 25
2.55×
Q1 25
2.62×
Q4 24
Q3 24
2.26×
Q2 24
2.56×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BKSY
BKSY

Segment breakdown not available.

CCLD
CCLD

Healthcare IT$31.0M90%
Medical Practice Management$3.4M10%

Related Comparisons